🇺🇸 FDA
Patent

US 8940701

Compounds for, and methods of, treating cancer and inhibiting invasion and metastases

granted A61KA61K31/337A61K38/08

Quick answer

US patent 8940701 (Compounds for, and methods of, treating cancer and inhibiting invasion and metastases) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/337, A61K38/08, A61K45/06, A61P